Bibliography
- Filigheddu F , ArgiolasG, TroffaC, GloriosoN: Essential hypertension: translating pathophysiology into pharmacogenomics.Current Pharmacogenomics4 , 219–229 (2006).
- Filigheddu F , ReidJE, TroffaC et al.: Genetic polymorphisms of the β-adrenergic system: association with essential hypertension and response to β-blockade.Pharmacogenomics J.4(3) , 154–160 (2004).
- Johnson JA , ZinehI, PuckettBJ, McGorraySP, YarandiHN, PaulyDF: β 1-adrenergic receptor polymorphisms and antihypertensive response to metoprolol.Clin. Pharmacol. Ther.74(1) , 44–52 (2003).
- Jia H , HingoraniAD, SharmaP et al.:Association of the G(s)α gene with essential hypertension and response to β-blockade. Hypertension34(1) , 8–14 (1999).
- Jia H , SharmaP, HopperR, DickersonC, LloydDD, BrownMJ: β2-adrenoceptor gene polymorphisms and blood pressure variations in East Anglian Caucasians.J. Hypertens.18 , 687–693 (2000).
- Kotanko P , BinderA, TaskerJ et al.: Essential hypertension in African Caribbeans associates with a variant of the β2-adrenoceptor.Hypertension30 , 773–776 (1997).
- Xie HG , SteinCM, KimRB et al.: Human β2-adrenergic receptor polymorphisms: no association with essential hypertension in black or white Americans.Clin. Pharmacol. Ther.67 , 670–675 (2000).
- Clark AG : The role of haplotypes in candidate gene studies.Genet. Epidemiol.27 , 321–333 (2004).
- Shastry BS : SNPs and haplotypes: genetic markers for disease and drug response.Int. J. Mol. Med.11(3) , 379–382 (2003).
- Daly MJ , RiouxJD, SchaffnerSF, HudsonTJ, LanderES: High-resolution haplotype structure in the human genome.Nat. Genet.29(2) , 229–232 (2001).
- Wagoner LE , CraftLL, ZengelP et al.: Polymorphisms of the β1-adrenergic receptor predict exercise capacity in heart failure.Am. Heart J.144(5) , 840–846 (2002).
- Herrmann SM , NicaudV, TiretL et al.: Polymorphisms of the β2-adrenoceptor (ADRB2) gene and essential hypertension: the ECTIM and PEGASE studies.J. Hypertens.20(2) , 229–235 (2002).
- Rosskopf D , BuschS, MantheyI, SiffertW: G protein β 3 gene: structure, promoter, and additional polymorphisms.Hypertension36(1) , 33–41 (2000).
- Binder A , GarciaE, WallaceC et al.: Haplotypes of the β-2 adrenergic receptor associate with high diastolic blood pressure in the Caerphilly prospective study.J. Hypertens.24(3) , 471–477 (2006).
- Bao X , MillsPJ, RanaBK et al.: Interactive effects of common β2-adrenoceptor haplotypes and age on susceptibility to hypertension and receptor function.Hypertension46(2) , 301–307 (2005).
- Wallerstedt SM , ErikssonAL, OhlssonC, HednerT: Haplotype association analysis of the polymorphisms Arg16Gly and Gln27Glu of the adrenergic β2 receptor in a Swedish hypertensive population.J. Hum. Hypertens.19(9) , 705–708 (2005).
- Lee YW , OhVM, GarciaE et al.: Haplotypes of the β2-adrenergic receptor gene are associated with essential hypertension in a Singaporean Chinese population.J. Hypertens.22(11) , 2111–2116 (2004).
- Cappello N , RendineS, GriffoR et al.: Genetic analysis of Sardinia: I. data on 12 polymorphisms in 21 linguistic domains.Ann. Hum. Genet.60(Pt 2) , 125–141 (1996).
- Chobanian AV , BakrisGL, BlackHR et al.: National Heart, Lung, and Blood Institute Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure; National High Blood Pressure Education Program Coordinating Committee. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report.JAMA289(19) , 2560–2572 (2003).
- Martinez FD , GravesPE, BaldiniM, SolomonS, EricksonR: Association between genetic polymorphisms of the β2-adrenoceptor and response to albuterol in children with and without a history of wheezing.J. Clin. Invest.100(12) , 3184–3188 (1997).
- Siffert W , RosskopfD, SiffertG et al.: Association of a human G-protein β3 subunit variant with hypertension.Nat. Genet.18(1) , 45–48 (1998).
- Mander AP : Analysis of quantitative traits using regression and log-linear modeling when phase is unknown.Stata J.2(1) , 65–70 (2002).
- Barrett JC , FryB, MallerJ, DalyMJ: Haploview: analysis and visualization of LD and haplotype maps.Bioinformatics21(2) , 263–265 (2005).
- Cagliani R , FumagalliM, PozzoliU et al.: Diverse evolutionary histories for β-adrenoreceptor genes in humans.Am. J. Hum. Genet.85(1) , 64–75 (2009).
- Camussi A , BianchiG: Genetics of essential hypertension. From the unimodal-bimodal controversy to molecular technology.Hypertension12(6) , 620–628 (1988).
- Bhatnagar V , O‘ConnorDT, BrophyVH et al.: G-protein-coupled receptor kinase 4 polymorphisms and blood pressure response to metoprolol among African Americans: sex-specificity and interactions.Am. J. Hypertens.22(3) , 332–338 (2009).
- Bianchi G , StaessenJA, FerrariP: Pharmacogenomics of primary hypertension – the lessons from the past to look toward the future.Pharmacogenomics4(3) , 279–296 (2003).
- Drysdale CM , McGrawDW, StackCB et al.: Complex promoter and coding region β 2-adrenergic receptor haplotypes alter receptor expression and predict in vivo responsiveness.Proc. Natl Acad. Sci. USA97(19) , 10483–10488 (2000).
- Hoehe MR , KöpkeK, WendelB et al.: Sequence variability and candidate gene analysis in complex disease: association of µ opioid receptor gene variation with substance dependence.Hum. Mol. Genet.9(19) , 2895–2908 (2000).
- Martin ER , LaiEH, GilbertJR et al.: SNPing away at complex diseases: analysis of single-nucleotide polymorphisms around APOE in Alzheimer disease.Am. J. Hum. Genet.67(2) , 383–394 (2000).
- Shin J , LobmeyerMT, GongY et al.: Relation of β2-adrenoceptor haplotype to risk of death and heart transplantation in patients with heart failure.Am. J. Cardiol.99 , 250–255 (2007).
- Zee RYL , CookNR, ReynoldsR, ChengS, RidkerPM: Haplotype analysis of the β2 adrenergic receptor gene and risk of myocardial infarction in humans.Genetics169 , 1583–1587 (2005).
- Li B , GeD, WangY et al.: G protein β 3 subunit gene variants and essential hypertension in the northern Chinese Han population.Ann. Hum. Genet.69(Pt 4) , 468–473 (2005).
- Pacanowski MA , GongY, Cooper-DehoffRM et al.: β-adrenergic receptor gene polymorphisms and β-blocker treatment outcomes in hypertension.Clin. Pharmacol. Ther.84(6) , 715–721 (2008).
- Bhatnagar V , O‘ConnorDT, BrophyVH et al.: G-protein-coupled receptor kinase 4 polymorphisms and blood pressure response to metoprolol among African Americans: sex-specificity and interactions.Am. J. Hypertens.22(3) , 332–338 (2009).
- Petrone A , ZavarellaS, IacobellisG et al.: Association of β2 adrenergic receptor polymorphisms and related haplotypes with triglyceride and LDL-cholesterol levels.Eur. J. Hum. Genet.14(1) , 94–100 (2006).
- Vargas-Alarcón G , FragosoJM, Cruz-RoblesD et al.: Association of adrenergic receptor gene polymorphisms with different fibromyalgia syndrome domains.Arthritis Rheum.60(7) , 2169–2173 (2009).
- Watkins WS , HuntSC, WilliamsGH et al.: Genotype–phenotype analysis of angiotensinogen polymorphisms and essential hypertension: the importance of haplotypes.J. Hypertens.28(1) , 65–75 (2009).
- Niu W , QiY, HouS, ZhaiX, ZhouW, QiuC: Haplotype-based association of the renin-angiotensin-aldosterone system genes polymorphisms with essential hypertension among Han Chinese: the Fangshan study.J. Hypertens.27(7) , 1384–1391 (2009)
- Mansego ML , RedonJ, MarinR et al.: Renin polymorphisms and haplotypes are associated with blood pressure levels and hypertension risk in postmenopausal women.J. Hypertens.26(2) , 230–237 (2008).
- Liu H , ZhangS, JiangS et al.: Renin-angiotensin-aldosterone system gene polymorphisms and antihypertensive response to irbesartan in Chinese hypertensives.Methods Find. Exp. Clin. Pharmacol.30(4) , 307–312 (2008).
- Su X , LeeL, LiX et al.: Association between angiotensinogen, angiotensin II receptor genes, and blood pressure response to an angiotensin-converting enzyme inhibitor.Circulation115(6) , 725–732 (2007).
- Medical Research Council Working Party on Mild Hypertension: Course of blood pressure in mild hypertensives after withdrawal of long term antihypertensive treatment. Br. Med. J. (Clin. Res. Ed.)293 , 988–992 (1986)
- Bianchi G , ManuntaP, GloriosoN: Clinical impact of adducin polymorphism.J. Hypertens.27(6) , 1325–1327 (2009).
- Forleo C , SorrentinoS, GuidaP et al.: β1- and β2-adrenergic receptor polymorphisms affect susceptibility to idiopathic dilated cardiomyopathy.J. Cardiovasc. Med. (Hagerstown)8(8) , 589–595 (2007).
- Iacoviello M , ForleoC, SorrentinoS et al.: α- and β-adrenergic receptor polymorphisms in hypertensive and normotensive offspring.J. Cardiovasc. Med. (Hagerstown)7(5) , 316–321 (2006).
- Pinelli M , GiacchettiM, AcquavivaF et al.: β2-adrenergic receptor and UCP3 variants modulate the relationship between age and Type 2 diabetes mellitus.BMC Med. Genet.7 , 85 (2006).